
Soon-Shiong’s NantWorks invests $50M in Precision Biologics
Precision Biologics, a Maryland developer of cancer immunotherapies and companion diagnostics, just received a $50 million investment from billionaire Patrick Soon-Shiong's mega-startup, NantWorks.